For pediatric patients, Is anyone using pre-mixed tranexamic acid bags (instead of vials) for anesthesia/OR use to prevent the possibility of intrathecal administration? If yes, have you had any issues with fluid overload (pre-mixed bag more dilute 10 mg/mL)? Thank you! -Nick

Do you have any policies or SOPs that you would be willing to share if your hospital allows bulk items (inhalers, insulin pens, ointments, creams, etc.) to relabeled at discharge to send home with the patient.

Sondra May
Children's Hospital Colorado

Our organization utilizes Baxter Spectrum IQ pumps and have had some of issues with TPNs running dry faster than expected. Initial biomed reports are finding that they may be running faster than the typical 5% variance/allowance. Anyone else experiencing anything similar?

We have gotten several reports lately from nursing of a failure of the hanger attached to the propofol vials and the product falling and shattering on the floor. The product in question is from Hospira, lot # LJ5801 and expiration 5/31/2027. Anyone else experiencing the same situation?

How many organizations have limited provider's ability to create personal preference lists and make modifications to order sets?

Hi my health system is reviewing storage and distribution for Creon being that the manufacture recommends storing the medication in the original bottle. I am seeking to see what work processes other institutions have done regarding properly storing, dispensing, and keeping inventory of this medication in the automated dispensing cabinets?

Hello MSOS Members,

We have very low number of ADR reporting and one of the ideas is to review naloxone use after opioid administrations during hospitalizations. Would you mind sharing how you do it (if you include naloxone in your ADR data)?

Thank you in advance for your time,

Manisa

Hello MSOS Members - Would you mind sharing what are your metrics for NPSG AC management, benchmark use and opportunities for improvement at your institutions.

Thank you in advance for your help!

Hello,

We typically stock meperidine 25 mg/mL single dose vials/carpujects (currently on ASHP shortage list), however we were able to purchase an alternative concentration to have the medication available temporarily. Has anyone been able to implement an effective way to emphasize a different concentration is being stocked compared to our usual product?

Per ASHP drug shortage information, the listed available meperidine product is a 50 mg/mL, 30 mL multiple dose vial. Does anyone have plans to use this product, and if yes what safeguards are you planning to implement?

We are starting the process of looking at our high-alert medication list since our last update a few years ago. I would appreciate any information (list or policy) that other pediatric institutions have and any strategies your institution uses if a double check process is not required around a high alert medication. Thanks!